SAN FRANCISCO--(BUSINESS WIRE)--Ossium Health, a clinical-stage bioengineering company with a first-of-its-kind bone marrow banking platform for processing and deploying hematopoietic stem cells ...

Ossium Health is a bioengineering company that leverages its proprietary organ donor bone marrow banking platform to develop stem cell therapies for patients with life-threatening blood and immune ...

To help increase the chances of these patients getting life-saving treatment, the bioengineering company Ossium Health has created a program that offers deep-frozen bone marrow from deceased organ ...

SAN FRANCISCO--(BUSINESS WIRE)--Ossium Health, a bioengineering company leveraging stem cell science to develop treatments for diseases of the blood and immune systems, has been named as a winner ...

Humacyte, a bioengineering company, went public through a SPAC merger in 2015, with a market value of $1.1 billion. The company has received FDA's RMAT designation for three indications ...

SAN FRANCISCO, July 30, 2024--(BUSINESS WIRE)--Ossium Health, a bioengineering company that entered the orthobiologics field in 2023, announced the first surgery using its next-generation viable ...

More than 100 employees from Ginkgo Bioworks, a Boston-based bioengineering company, are facing layoffs between August and December, according to a state database. In total, 158 employees in the ...

Sometime in 2023, Minnesota-based bioengineering company Miromatrix plans first-of-its-kind human testing of a bioengineered organ to start trying to prove it If the Food and Drug Administration ...

Few people are making more intriguing use of it than Kenneth Savin, chief scientist of Redwire, a bioengineering company specializing in manufacturing protein crystals and human tissue in the ...